Plateau on the top GLP-1 dose: how often will a clinician check in?

Every month the same check-in arrives. You report your weight and any side effects, then confirm you are still taking the medication. A telehealth clinician you have not met spends about 15 minutes on the file and signs off the refill. For a while, the dose rose each time the weight slowed. Now you are on the highest dose the medication comes in. The scale has not moved in weeks. When you asked what comes next, you were told there is nothing else to try.

If you have reached a plateau on the top GLP-1 dose and are thinking about moving your care, the question you are probably typing is a practical one. How fast will I hear from a clinician and how often? This piece answers both halves plainly, including the part we will not promise. It also answers the question underneath them, which is whether anyone will look for the reason the weight stopped moving.

GoodLife Health is a clinician-led membership that looks for the reason behind a GLP-1 plateau before the dose or the medication changes. It draws cardiometabolic labs before the prescription and every quarter after. Its care team answers by message between visits. If you would like to know first whether a clinician can take you on, start with the eligibility check.

Fifteen minutes a month and nothing new to read

The monthly sign-off feels like care because it is regular. Someone opens your file on a schedule and a refill follows. When the weight was falling, that seemed enough. Nobody had a reason to ask more of it.

The plateau changed the question. The service kept asking the old one, which is whether to continue. Nothing in that question explains why the weight stopped. Think back to the last time anyone drew your blood. For some people in your position, the answer is before the first prescription. For others, the answer is never.

Then there is the cost. Every month at the top dose, you pay for the medication. It may come from a compounding pharmacy or from a retail pharmacy at a branded price. You pay either way, whether or not it is still doing what you started it to do. You also pay in a way that does not show up on a statement. You did everything that was asked of you. Now you are told the effort has reached its end.

None of this means the clinician who signs your refill is careless. The service was built for a narrower task than the one you now need. The 15 minutes reflect that task. A clinician with a short slot and a long queue can confirm that nothing is wrong with the refill. That clinician cannot work up a plateau in the same slot. The check-in gives them nothing new to work with.

The phrase “there is nothing else to try” deserves a closer look. It may be an accurate description of what one service offers. It is a much larger claim to say that medicine has nothing more to offer you. The two are easy to confuse when you have watched the same number on the scale for weeks.

Why a refill visit cannot answer a plateau

A refill model is built around one decision: continue, increase or stop. The visit is short because the decision is narrow. Each step up the dose ladder is a yes or a no. Fifteen minutes fit that decision well. When the ladder ends at the highest dose, the model has no next step. In that sense, the sentence you heard was accurate about the model.

The question of how often you are seen sits inside this. Monthly contact is frequent. Frequency helps only when each contact can add something. A check-in that never measures anything new can only repeat the last answer, however often it happens.

Cardiometabolic care has been moving toward testing before treating. Fasting Insulin and Apolipoprotein B (ApoB) now sit in the panel where glucose and LDL once stood alone. A plateau at the top dose raises questions that a weight and a side-effect report cannot reach.

• What does Fasting Insulin show now, read beside Hemoglobin A1c (HbA1c)?
• What do the Lipid Panel, Standard and Apolipoprotein B (ApoB) look like after months on the medication?
• What does TSH With Reflex To Free T4 say about the thyroid?
• Is the medication you are on the right one for you or is another branded option worth a clinician's consideration?

We do not know which of these, if any, matters in your case. Nobody can know that from a refill check-in, which is the reason to draw the panel before deciding anything.

The branded options are also wider than one pen. Wegovy contains semaglutide, while Zepbound contains tirzepatide. Mounjaro and Ozempic are on the formulary too. Wegovy is also sold as a pill. Whether any change is indicated for you is a clinical decision. A clinician makes it after the labs, with your history in front of them and with you.

If your medication comes from a compounding pharmacy, one more fact belongs here. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss. GoodLife Health prescribes branded, FDA-approved medication only. A clinician's license carries the responsibility for every prescription written. If you are moving from a compounded product, the clinician reviews your current dose and decides the next step with you.

There is one more reason a refill model stops at the top dose. When a service earns its revenue on the medication it ships, its visits exist in part to keep the medication moving. That describes a business model. GoodLife Health takes nothing on what it prescribes. Its clinicians have no financial reason to keep you on a medication that has stopped helping or to move you onto one that has not been shown to fit.

How fast and how often, in plain terms

The cadence below begins with the one thing we will not promise, then sets out the rest.

How fast you hear from a clinician

GoodLife Health does not publish a response time for messages. The care team answers by message between visits. We would rather say that plainly than print a number we might miss on a busy day. If a message seems to sit too long, tell the care team. The guide to a direct primary care visit gives the same advice.

The same honesty applies to the start. The path is the eligibility check, then the intake, then the checkout, then a clinician's review. We do not promise how long that review takes. What happens to your money is fixed. At checkout, $598 is held on your card to cover the first two months. It is a hold. It is charged only once the clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable.

How often a clinician reads your numbers

The membership includes four cardiometabolic lab panels a year, one every 90 days. Each panel draws Fasting Insulin and Hemoglobin A1c (HbA1c), which the clinician reads together. Each carries Apolipoprotein B (ApoB), Lipoprotein (A) and Hs-CRP beside the Lipid Panel, Standard. Each includes TSH With Reflex To Free T4. Every result is in your hands, which matters if you have spent months without seeing a single number of your own.

A clinician reads each panel with you. The first panel sets a baseline that your current service may never have drawn. The panels after it show whether insulin, A1C and the lipids are moving while the scale holds still. A plateau read against that record is a different conversation from a plateau read against a weight alone.

This is also what frequency means here. You can write to the care team whenever something changes, so you may hear from it far more often than once a quarter. The clinician looks at new numbers four times a year. Those are two different rhythms. Both are part of the answer to how often.

Video visits are included in the fee. Your clinician schedules them around the results. Between them, you message the care team with a side effect, a question about a result or a change you have noticed.

GoodLife Health's clinicians are licensed in all 50 states. The clinician who reads your first panel stays with you for the panels that follow.

What happens to the medication

When a medication is clinically indicated, it is prescribed to the pharmacy you choose at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. The fee is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge.

The manufacturers publish their own self-pay prices. In prices published in September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills (an introductory offer for new patients through December 2026) and at $349 a month after. The Wegovy pill is listed from $149 a month at lower doses. Through LillyDirect, Zepbound vials cost $299 to $449 a month depending on dose. Whether insurance covers any of these is between you, your plan and your pharmacy. Prior authorization is the pharmacy's process. We do not run it and we do not promise its outcome.

Why pay a membership when the drug is the expensive part?

This is a fair objection. If another service will keep renewing a prescription, the membership has to buy something the renewal cannot. What it buys is the workup and the follow-through: the panel before any change, the same clinician reading it every quarter and a care team you can message between visits. The membership is $299 a month, which comes to $3,588 a year.

It is built on a different principle. The people treating you earn nothing more when they prescribe more or prescribe something else.

If you already have a prescriber, keep that in mind as you decide. That prescriber may have told you there is nothing else to try. A membership makes sense only if you want a second clinician to look for a reason with new data in hand.

What the membership does not do

It does not promise that the weight will move again. No honest clinician can promise that. We do not. It does not prescribe compounded GLP-1 or promise a message response time. It does not replace your insurance, which still covers the hospital and the catastrophic event. It does not promise that a medication will be covered or that prior authorization will succeed. It is precision direct primary care for cardiometabolic health, which is a narrower scope than every kind of doctor you may one day need. The guide to what a direct primary care membership includes sets out where membership care ends and insurance begins.

What you can do this week, whether or not you join

Start with your current service. Ask for a lab panel before your next refill and name the markers: Fasting Insulin, Hemoglobin A1c (HbA1c), TSH With Reflex To Free T4 and a Lipid Panel, Standard with Apolipoprotein B (ApoB). If the service cannot order them, you have learned something useful about what it was built to do.

Write one page of history. List each dose, the month you started it and what the scale did in the weeks that followed. Note any side effects and when they began. Any clinician you see next can use that page, here or elsewhere.

Ask your prescriber one specific question: what was ruled out before you were told there was nothing else to try? You deserve a direct answer. It may be the sentence you least want to hear: “Nothing was checked.”

Call your plan to ask whether it covers a branded GLP-1 such as Wegovy or Zepbound. Ask your pharmacy what it would need for prior authorization. The answers will be yours to act on, whichever clinician writes the prescription.

We cannot tell you from here why your weight stopped moving. We cannot tell you whether a change of medication is indicated. What we can tell you is how often someone will look, what they will measure and what it costs. The rest belongs to a clinician with your numbers.

Who this is not for

If you want a refill renewed each month and nothing more, a refill-only service will do that. Keep it. If you want compounded GLP-1, we do not prescribe it. If you want a promised result, a promised response time or a promise that insurance will pay, we make none of those promises. If you need help within hours for something urgent, call your local urgent care or emergency services. The membership is open only to people who live in the United States. Not every applicant is accepted. A clinician's review decides.

For everyone else, the offer is easy to state. GoodLife Health is $299 a month. At checkout, $598 is held on your card for the first two months and is charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, those two months are charged and are non-refundable. From month three, the membership is month to month. The fee buys four cardiometabolic panels a year and a clinician who stays. It covers messaging with the care team between visits as well as video visits. Medication is prescribed when indicated to your own pharmacy at that pharmacy's price. GoodLife Health takes nothing on it and medication billed by a pharmacy follows that pharmacy's own return and refund policy. What the membership returns is the workup your refills never produced and your markers followed every 90 days. It is different because it tests first, treats second and sells neither the drug nor the dose. If you are at the top dose with no plan beyond the next refill, each month of waiting will look like the last one.

Related Reading

• What a Direct Primary Care Visit Actually Looks Like (2026)
• What Does a Direct Primary Care Membership Include in 2026

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss